ArticleOncogene2025

BEX4 inhibits the progression of clear cell renal cell carcinoma by stabilizing SH2D4A, which is achieved by blocking SIRT2 activity.

Ziyao Li et al.PubMed ↗Publisher ↗

No numbers read from the abstract.